cp 96345 has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitrovic, I; Napier, TC | 2 |
| Bannerman, P; Commons, KG; Douglas, SD; Ho, C; Ho, W; Lai, J; Pleasure, DE; Wang, X; Williams, M | 1 |
3 other study(ies) available for cp 96345 and enkephalin, ala(2)-mephe(4)-gly(5)-
| Article | Year |
|---|---|
Interactions between the mu opioid agonist DAMGO and substance P in regulation of the ventral pallidum.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Biphenyl Compounds; Electrophysiology; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Extracellular Space; Globus Pallidus; Iontophoresis; Male; Microelectrodes; Neural Conduction; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance P; Tachykinins | 1996 |
Substance P attenuates and DAMGO potentiates amygdala glutamatergic neurotransmission within the ventral pallidum.
Topics: Amygdala; Analgesics, Opioid; Animals; Biphenyl Compounds; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Evoked Potentials; Globus Pallidus; Glutamic Acid; Hypnotics and Sedatives; Male; Neurons; Neurotransmitter Agents; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reaction Time; Stimulation, Chemical; Substance P; Synaptic Transmission | 1998 |
A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons.
Topics: Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Humans; Morphine; Neurons; NF-kappa B; Promoter Regions, Genetic; Substance P | 2004 |